2026年10月22日 8:30 ET 发布 · 更新于 23 天前 · 1 个来源
All-or-Nothing Biotech Bets Dented by Rising Treasury Yields
bloomberg
·
原始报道
Investors are beginning to turn cautious on biotechnology stocks as a rapid rise in Treasury yields dents the appeal for shares of companies that are often viewed as risky all-or-nothing bets on breakthrough medical treatments.
原文